FDA’s Drug Pedigree Enforcement To Focus Initially On High-Risk Products
FDA will adopt a phased-in approach to enforcing drug pedigree requirements in the upcoming year
FDA will adopt a phased-in approach to enforcing drug pedigree requirements in the upcoming year